Join Vasuda Healthcare Analytics, and invest with Bhavneesh Sharma, MBBS, MD, MBA (Finance, NYU-Stern)

NYSE interview.png

I invite you to try Vasuda Healthcare Analytics, premium US Biotech/Pharma event-driven investment research service (available in Seeking Alpha's Marketplace), members include money managers and sell-side analysts.

I have 20-years of clinical and research experience in academic and private practice/community settings, including at Harvard and Cornell affiliated hospitals including medical director position. I have several highly cited peer reviewed scientific publications and won Young Investigator Award twice at the international level. I also have an MBA in Finance, Financial Markets specialization from New York University's Stern School of Business (ranked among top 3 finance MBA programs in the U.S.) and perform my own DCF valuations. I also run a biotech/pharma focused investment management firm.

I am ranked among the top 25 financial bloggers on Tipranks based on the performance of stock picks.

The main strategy is event-driven, i.e. covering companies with near-term catalysts like data releases, PDUFA, etc. There is also a long-term portfolio. There are also several contrarian picks.

Successful picks have included Juno Therapeutics (picked after clinical hold), Alnylam Pharmaceuticals (picked after clinical hold), Dynavax (doubled after CRL), Neurocrine Biosciences, Sage Therapeutics, Sarepta Therapeutics (picked after negative Adcom), Zogenix, Editas medicine, Teva Pharmaceuticals (picked after the drop below $15), Tobira (picked after trial failure, etc.). Few companies which were acquired include Tobira Therapeutics (a record 7x premium), Juno Therapeutics, Armo Biosciences, etc. 

Subscriber-only benefits include:

  • Weekly market and macroeconomic updates to assess the market direction in the short-term and intermediate term. Some market timing can greatly enhance your biotech portfolio returns.

  • Two model portfolios: event-driven and long-term

  • Regular updates on the companies in the portfolios.

  • A weekly list of best buys from the portfolio with new money based on various factors.

  • An opportunity to ask my Buy/Sell/Hold view on subscriber suggested investment ideas (I have a long list but will work through them).

  • Some investment ideas are exclusive to the premium service and are not released on the public Seeking Alpha website.

  • Earlier access to the investment ideas that are released publicly on Seeking Alpha.

  • Real-time Buy/Sell alerts on short-term trades (including options) via a subscriber-only twitter account and chat room.

  • A separate chat room for trading emini S&P 500 futures and biotech ETF (XBI) based on support/resistance levels as an added bonus.

These subscriber only features are not available on my contributions on the public Seeking Alpha site. 

We also a panel of specialists to consult when needed.

Join our investor community today to invest smarter in the biotech/pharma sectors. A free trial is available for a limited time.

Bhavneesh Sharma, MBBS, MD, MBA 
- Founder/Editor, Vasuda Healthcare Analytics
- Insights contributor, SumZero's Buy-side Institutional Platform 
- Founder, Vasuda Capital Management 

(Linkedin profile) 


Monthly plan: free 14-day trial, then $50/month

Annual Plan: free 14-day trial, then $400/year), less than a small coffee/day: 30% savings.